DataVXAdvanced MaterialsPaper
journal article·2016-06

Upconversion Nanoparticles: On The Latest Three‐Stage Development of Nanomedicines based on Upconversion Nanoparticles (Adv. Mater. 21/2016)

Wenpei Fan, Wenbo Bu, Jianlin Shi

Advanced Materials· Volume 28· Issue 21
Publisher page
Source abstract

Abstract

The latest three-stage development of nanomedicines based on upconversion nanoparticles (UCNPs) in optimizing single treatment (e.g., NIR-triggered drug release, etc.), achieving multimodal synergetic therapy (e.g., chemo-/radiotherapy) and overcoming tumor hypoxia (e.g., disruption of hypoxic tumor, etc.) are discussed by W. Bu and co-workers on page 3987. Such UCNP-based nanomedicines may contribute significantly to promoting the clinic-translational applications of UCNP-based nanomedicines.
Source: openalex_inverted_index · Quality: baseline

Research context

Nanomaterials

OpenAlex topics: Nanoplatforms for cancer theranostics · Medical Imaging Techniques and Applications · Boron Compounds in Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of High performance Ceramics and Superfine Microstructures Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China

Laboratory of Molecular Imaging and Nanomedicine (LOMIN) National Institute of Biomedical Imaging and Bioengineering (NIBIB) National Institutes of Health (NIH) Bethesda MD 20892 USA

Shanghai Key Laboratory of Green Chemistry and Chemical Processes School of Chemistry and Molecular Engineering East China Normal University Shanghai 200062 P. R. China

References

Reference metadata was not supplied for this record.